// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Results of LITMUS (NCT 02541916): The Liver Immune Tolerance Bio Marker Utilization Study

A. Chruscinski - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

RNA Expression Profiling of Renal Allografts in a Non-Human Primate Identifies Inflammation as a Risk Factor in Chronic Antibody Mediated Rejection

R. Smith - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Other

N/A

Interferon

RNA Expression Profiling of Renal Allografts in the Cynomolgus Monkey Identifies Tolerance

R. Smith - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Other

N/A

N/A

RNA-Seq Based Analysis of Renal Allograft Biopsies Reveals Key Mediators of Interstitial Fibrosis/Tubular Atrophy

C. McEvoy - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

Safety and Tolerability of Therapy for Latent Tuberculosis Infection: A 16-Year Review

Y. AlJishi - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

Serum Cytokines as Markers of Influenza Infection Outcomes after Transplantation

A. L'Huillier - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

Interleukin-10

Single vs. Multi-Drug Antibiotic Prophylaxis for Continuous-Flow Left Ventricular Assist Device Implantation: A Systematic Review and Meta-Analysis

S. Patel - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

South Asian and Muslim Canadian Patients Are Less Likely to Receive Living Donor Kidney Transplant Offers Compared to Caucasian, Non-Muslim Patients

A. Ali - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Surveillance for Mycoplasma/Ureaplasma Infection in Lung Transplant Recipients (LTRs)

L. Somerville - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

T Cell-Mediated Rejection Poses Greater Risk to Graft Survival Than Antibody-Mediated Rejection in Heart Transplants

M. Parkes - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Other

N/A

N/A

Taking Specific Steps to Pursue Living Donor Kidney Transplant is Associated with Greater Odds of Having a Potential Living Donor Identified

A. Ali - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

Targeting Calcium Release-Activated Calcium (CRAC) Channel in Non-Human Primate Kidney Transplantation

J. Kwun - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Tacrolimus

Temporal Trends in Living Kidney Donor Candidates

S. Singh - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

The Association between Transplant Glomerulopathy and Graft Outcomes among Patients Undergoing Kidney Transplantation: Results of a Meta-Analysis

G. Kovacs - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Impact of Childhood Solid Organ Transplantation on B-Cell Maturation

L. Ionescu - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Impact of Donor Specific Alloantibodies on Long-Term Outcomes of Liver Re-Transplantation

Q. Xu - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Prognostic Implications of Renal Function Recovery and Delayed Graft Function in Kidney Transplantation

S. Sandal - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

Time and Perfusate Dependent Molecular Response in Ex Vivo Lung Perfusion

P. Dromparis - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Tipping the “Immune Balanceâ€ towards Tolerance by Specific and Systematic Depletion of Donor and Host Effector Cells

R. Bascom - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Transplant Candidates and Potential Living Kidney Donors Are Supportive of Reciprocity for Transplant Candidates Who Participate in Kidney Paired Donation with a Compatible Donor

J. Gill - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved